Sage Journals: Discover world-class research

Abstract

An increased risk of vaccine-preventable infections (VPIs) is seen in people living with HIV (PLWH), and current vaccine coverage and immunity is variable. Vaccine passports have the potential to improve vaccine coverage. The objective was to assess how successful a vaccine passport was in improving vaccine coverage in PLWH. Baseline immunity to VPIs was established in PLWH attending a single HIV clinic and vaccinations required were determined based on the BHIVA Vaccination Guidelines (2015). The passport was completed and the PLWH informed about additional vaccines they should obtain from primary care. After 6–9 months the passport was reviewed including confirmation if vaccines were given. PLWH satisfaction with the system was evaluated by a survey. Seventy-three PLWH provided sufficient data for analysis. At baseline significant proportions of PLWH were not immune/unvaccinated to the main VPIs, especially human papillomavirus, pneumococcus and measles. After the passport was applied immunity improved significantly (56% overall, p < 0.01) for most VPIs; however, full coverage was not achieved. The system was popular with PLWH. The passport was successful in increasing vaccination coverage although full or near-full coverage was not achieved. A more successful service would probably be achieved by commissioning English HIV clinics to provide all vaccines.

Keywords

HIV vaccine immunisation passport

Get full access to this article

View all access options for this article.

References

Yin

Rice

Waight

et al . Invasive pneumococcal disease among HIV-positive individuals, 2000–2009. AIDS 2012; 26: 87–94.

British

HIV.

Association guidelines on the use of vaccines in HIV-positive adults, http://www.bhiva.org/documents/Guidelines/Vaccination/2015-Vaccination-Guidelines.pdf (2015, accessed 12 February 2018).

Molton

Smith

Chaytor

et al . Seroprevalence of common vaccine-preventable viral infections in HIV-positive adults. J Infect 2010; 61: 73–80.

BHIVA National Audit. Routine monitoring and assessment of adults with HIV, http://www.bhiva.org/documents/Conferences/Autumn2015/Presentations/151112/AoifeMolloy.pdf (2015, accessed 12 February 2018).

HSE National Immunisation Office. Vaccination passport. https://www.hse.ie/eng/health/immunisation/infomaterials/pubs/engpassportnew.pdf (2013, accessed 12 February 2018).

Finnegan G. EU considers ‘vaccination passport’ for kids. https://www.vaccinestoday.eu/stories/eu-considers-vaccination-passport-for-kids/ (2011, accessed 12 February 2018).

Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America, https://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_OI.pdf (2018, accessed 12 February 2018).

8World Health Organization Europe. Edited by Irina Eramova, Srdan Matic and Monique Munz. HIV/AIDS treatment and care: clinical protocols for the WHO European region 2007, http://www.euro.who.int/__data/assets/pdf_file/0004/78106/E90840.pdf (2015, accessed 12 February 2018).

European AIDS Clinical Society (EACS). Guidelines for the treatment of HIV. Version 8.2, http://www.eacsociety.org/guidelines/eacs-guidelines/eacs-guidelines.html (2017, accessed 12 February 2018).

10.

World Health Organization. Vaccine position papers, http://www.who.int/immunization/documents/positionpapers/en/ (2018, accessed 12 February 2018).

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.08 MB